Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery-Reference-Cited by-同舟云学术

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery

Published:2019-09-19 Issue:9 Volume:14 Page:e0222012
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Moccia Marcello^ORCID,Tajani Andrea,Acampora Rosa,Signoriello Elisabetta,Corbisiero Guido,Vercellone Adriano,Sergianni Primo,Pennino Francesca,Lanzillo Roberta,Palladino Raffaele,Capacchione Antonio,Brescia Morra Vincenzo,Lus Giacomo,Triassi Maria

Funder

Merck KGaA

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Multiple sclerosis;AJ Thompson;Lancet,2018

2. Predictors of the 10-year direct costs for treating multiple sclerosis;M Moccia;Acta Neurol Scand,2017

3. Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015;M Moccia;PLoS One,2017

4. New insights into the burden and costs of multiple sclerosis in Europe: Results for Italy;M Battaglia;Mult Scler,2017

5. New natural history of interferon-beta-treated relapsing multiple sclerosis;M Trojano;Ann Neurol,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: A Japanese nationwide administrative data study;Multiple Sclerosis and Related Disorders;2024-01

2. The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis;Clinical Epidemiology;2022-11

3. A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP;Frontiers in Psychology;2022-08-24

4. Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis;Neurodegenerative Disease Management;2022-06

5. Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy);Multiple Sclerosis Journal;2022-03-25